The EBITDA margin fell to 21.5%, compared with 26.5% in the corresponding quarter of the previous fiscal. Shares of RPG Life Sciences Ltd ended at ₹2,295.00, down by ₹11.00, or 0.48%, on the BSE.
The EBITDA margin fell to 21.5%, compared with 26.5% in the corresponding quarter of the previous fiscal. Shares of RPG Life Sciences Ltd ended at ₹2,295.00, down by ₹11.00, or 0.48%, on the BSE.